Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
indicesnifty pharma
fundamentals

Nifty Pharma

Factsheet
Nifty Pharma Index captures the performance of the pharmaceutical sector. The Index comprises of 20 companies listed on National Stock Exchange of India (NSE). Nifty Pharma Index is computed using free float market capitalization method, wherein the level of the index reflects the total free float market value of all the stocks in the index relative to particular base market capitalization value. Nifty Pharma Index can be used for a variety of purposes such as benchmarking fund portfolios, launching of index funds, ETFs and structured products.
25,777.25468.3 (1.85%) D
Value
Quality

Value

We look at aggregate consolidated P/E, P/B and Dividend Yield of the index as reported by NSE. Note that P/E values before 31st March 2021 are based on our own calculations
Current
5.30
Average (3Y)
5.10
Average (5Y)
4.91
P/B ratio is shown as reported by NSE.

Quality

We look at aggregate quality measures of the index like ROE, ROCE and margins. Numerator and denominator are separately calculated as weighted averages.
Latest as on 30 Sep 2025
17.82

Frequently Asked Questions

What is the current P/E ratio of Nifty Pharma?
The current P/E ratio of Nifty Pharma is 38.67. Historical P/E trend charts are available in the Value section of the Fundamentals tab.
Is Nifty Pharma overvalued or undervalued based on current P/E?
Valuation context for Nifty Pharma — comparing current P/E and P/B to their historical averages — is available in the Value section of the Fundamentals tab.
What is the P/B ratio of Nifty Pharma?
The current P/B (Price-to-Book) ratio of Nifty Pharma is 5.30 Historical P/B trend charts are in the Value section of the Fundamentals tab.
What is the dividend yield of Nifty Pharma?
The aggregate dividend yield of Nifty Pharma is 0.62%. Dividend yield tends to be inversely related to market valuations — a lower yield often coincides with higher price multiples. Historical dividend yield data is in the Value section of the Fundamentals tab.
What is the 10-year average P/E of Nifty Pharma?
The 10-year average P/E of Nifty Pharma is shown in the Value section of the Fundamentals tab as a reference line on the historical P/E chart.
What is the ROE of Nifty Pharma's constituent stocks?
The aggregate Return on Equity (ROE) of Nifty Pharma constituents is 15.90%. ROE measures how efficiently constituent companies generate profit from shareholder equity. An ROE above 15% reflects strong capital efficiency in the index portfolio. Historical ROE trends are in the Quality section of the Fundamentals tab.
What is the ROCE of Nifty Pharma's constituent stocks?
The aggregate Return on Capital Employed (ROCE) of Nifty Pharma constituents is 17.82%, alongside a ROE of 15.90%. ROCE measures profitability relative to total capital (debt + equity) and is a better indicator of capital efficiency for debt-heavy sectors. Historical ROCE data is in the Quality section of the Fundamentals tab.
What is the net profit margin of Nifty Pharma's constituents?
The net profit margin and operating margin of Nifty Pharma's constituents are shown in the Quality section of the Fundamentals tab.
What are the quality metrics of Nifty Pharma?
Key quality metrics of Nifty Pharma constituents — ROCE: 17.82%, ROE: 15.90%, PAT margin: 17.79%, Operating margin: 22.15% — reflect the aggregate profitability and efficiency of the index portfolio. ROE of 15.90% indicates how well constituent companies utilise shareholder equity. The full quality breakdown with historical trends is in the Quality section of the Fundamentals tab.
What is the financial health of Nifty Pharma's constituents?
The financial health of Nifty Pharma's constituent companies — including debt ratios and interest coverage — is shown in the Financial Health section of the Fundamentals tab.